Alteration of energy production by the heart in CRF patients undergoing peritoneal dialysis

Molecular and Cellular Biochemistry

Volumn 244, Issue 1-2, 2003, Pages 135-138

  Ogimoto, Goichi ^a   Sakurada, Tsutomu ^a   Imamura, Keiko ^a   Kuboshima, Shingo ^a   Maeba, Teruhiko ^a   Kimura, Kenjiro ^a   Owada, Shigeru ^b  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Akabane Central Hospital   (Japan)

Author keywords

Chronic renal failure; Energy metabolism; Magnetic resonance spectroscopy; Myocardium

Indexed keywords

ADENOSINE TRIPHOSPHATE; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CREATINE PHOSPHATE; CREATININE; NITROGEN; PARATHYROID HORMONE; PHOSPHATE; PHOSPHORUS 31; UREA;

ADULT; BLOOD SAMPLING; CALCULATION; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ENERGY METABOLISM; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HEART MUSCLE; HEART SIZE; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN DETERMINATION; HORMONE DETERMINATION; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERITONEAL DIALYSIS; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; REVIEW; SYSTOLE; UREA NITROGEN BLOOD LEVEL;

ADENOSINE TRIPHOSPHATE; ADULT; ECHOCARDIOGRAPHY; FEMALE; HEART; HUMANS; KIDNEY FAILURE, CHRONIC; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MYOCARDIUM; PERITONEAL DIALYSIS; PHOSPHORUS RADIOISOTOPES; TIME FACTORS;

EID: 0037305058     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022470815270     Document Type: Review

References (22)

1. Horl WH, Riegel W: Cardiac depressant factors in renal disease. Circulation 87(supple IV): IV77-IV82, 1993
2. Akiba T (ed).: An Overview of Regular Dialysis Treatment in Japan, 2001, p 89
3. Kawaguchi T, Nishizawa Y, Konishi T et al.: High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int 48: 820-826, 1995
4. Gejo F, Yamada T, Odani S, Nakagawa Y et al.: A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobuli. Biophys Res Commun 129: 701-706, 1985
5. Isaacs H: Electromyographic study of muscle weakness in chronic renal failure. S A Med J: 683-688, 1969
6. Brautbar N: Skeletal myopathy in uremia: Abnormal energy metabolism. Kid Int 24: S81-S86, 1983
7. Van Es A, Henny FC, Kooista MP, Lobatto S, Scholtte HR: Amelioration of cardiac function by L-carnitine administration in patients on hemodialysis. Contrib Nephrol 92: 28-35, 1992
8. Kramer W, Wizemann V, Lämmlein, Thormann J, Kindler M, Schlepper M, Schütterle G: Cardiac dysfunction in patients on maintenance hemodialysis. Contrib Nephrol 52: 110-124, 1986
9. Kooman JP, Wijnen JAG, Draaijer P, van Bortel L, Gladziwa U, Struyker-Bboudier HAJ, Peltenburg HG, van Hooff JP, Leunissen KML: Compliance and reactivity of the peripheral venous system in patients treated with chronic intermittent hemodialysis. Kidney Int 41: 1041-1048, 1992
10. Ritz E, Rambausek M, Mall G, Ruffman K, Mandelbaum A: Cardiac changes to uremia and their possible relation to cardiovascular instability on dialysis. Contrib Nephrol 78: 221-229, 1990
11. Ogimoto G: Energy metabolism of skeletal muscle on chronic renal failure. St. Marianna Med J 20: 540-549, 1992
12. 31P MR spectroscopy at 1.5T. NMR Biomed 7: 218-224, 1994
13. London GM, Guefin AP, Pannier B, Safar ME, Dat M, Metivier F: Cardiac and arterial interactions in end-stage renal disease. Kidney Int 50: 600-608, 1996
14. Hüting J, Kramer W, Reitinger J, Kühn K, Wizemann V, Schütterle G: Cardiac structure and function in continuous ambulatory peritoneal dialysis: Influence of blood purification and hypercirculation. Am Heart J 119: 344-352, 1990
15. Tagami T, Sakuma H, Matsumura K, Takeda K, Mori S, Takeuchi T, Nakano T: Evaluation of altered myocardial high energy phosphate metabolism in patients on maintenance dialysis using phosphorus-31 magnetic resonance spectroscopy. Invest Radiol 33: 171-176, 1998
16. Weiss RG, Bottomley PA, Hardy CJ, Gerstenblith G: Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease. N Engl J Med 323: 1593-1600, 1990
17. Schaefer S, Gober JR, Schwartz GG, Twieg DB, Weiner MW, Massie B: In vivo phosphorus-31 spectroscopic imaging in patients with global myocardial disease. Am J Cardiol 65: 1154-1161, 1990
18. Masuda Y, Tateno Y, Ikehira H et al.: High-energy phosphate metabolism of the myocardium in normal subjects and patients with various cardiomyopathies: The study using ECG gated MR spectroscopy with a localization technique. Jpn Circ J 56: 620-626, 1992
19. Hardy CJ, Weiss RG, Bottomley PA, Gerstenblith G: Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J 122: 795-801, 1991
20. Vaziri ND: Cardiovascular effects of erythropoietin and anemia correction Curr Opin Nephrol Hypertens 10: 633-637, 2001
21. Thompson CH, Kemp GJ, Taylor DJ, Radda GK: Bioenergetic effects of erythropoietin in skeletal muscle. Nephron 74: 239-240, 1996
22. Bremer J: Carnitine: Metabolism and functions. Physiol Rev 63: 1420-1480, 1983